TumCMig Cancer Research Results
TumCMig, Tumor cell migration: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell migration is a critical process in cancer progression and metastasis, which is the spread of cancer cells from the primary tumor to distant sites in the body.
|
ESCC, Oesophageal Squamous Cell Carcinoma: Click to Expand ⟱
Esophageal cancer is a growth of cells that starts in the esophagus.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
TumCP↓, TumCMig↓, Glycolysis↓, cycD1/CCND1↓, CDK4↓, ECAR↓, TumCCA↑, HK1↓, ALDH↓, ALDOA↓, PKM2↓, Hif1a↓,
| - |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
TumCP↓, Apoptosis↓, TumCMig↓, TumCCA↑, DNAdam↑, MAPK↓, γH2AX↑, TumMeta↓, TumCI↓, P21↑, ROS↑, EMT↓, ChemoSen↑,
TumCMig↓, TumCI↓, MMP9↓, p‑AMPK↑, SIRT1↑, NF-kB↓, p‑IκB↑,
*Inflam↓, TumCG↓, TumCP↓, TumCMig↓, TumCI↓, Apoptosis↓, TumCG↓, PI3K↓, p‑Akt↓, RAS↓, Raf↓, p‑ERK↓, Bcl-2↓, BAX↑,
| - |
in-vitro, |
ESCC, |
KYSE450 |
|
|
|
- |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
TumCG↓, TumCP↓, TumCMig↓, TumCI↓, angioG↓, Apoptosis↑, PI3K↓, Akt↓, p‑Akt↓, survivin↓, Bax:Bcl2↑, Casp3↑, Casp9↑, MMP2↓, MMP9↓, VEGF↓, EMT↓, eff↑, DNAdam↑, p‑STAT3↑, ChemoSen↑,
| - |
in-vitro, |
ESCC, |
KYSE-30 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE450 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑PARP1↑, cl‑Casp3↑, cl‑Casp9↑, PI3K↓, p‑Akt↓, p‑mTOR↓, PTEN↑,
| - |
vitro+vivo, |
ESCC, |
TE1 |
|
|
|
- |
vitro+vivo, |
ESCC, |
KYSE150 |
|
|
|
TumCP↓, TumCI↓, TumCMig↓, EMT↓, Apoptosis↑, RadioS↑, p‑STAT3↓, p‑Akt↓, p‑ERK↓,
Apoptosis↑, TumCMig↓, TumCI↓, β-catenin/ZEB1↓, cMyc↓, cycD1/CCND1↓,
| - |
vitro+vivo, |
ESCC, |
KYSE-30 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE70 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
tumCV↓, Apoptosis↑, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, PAK1↓, ChemoSen↑, cl‑PARP↑, Casp3↑, TumMeta↓,
TumCP↓, TumCMig↓, TumCI↓, MMPs↓, ROS↑, MMP↓, BAX↑, Casp3↑, Casp9↑, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, CycB/CCNB1↓, CDK1↓, P53↑, TumCG↓, toxicity↓,
| - |
in-vitro, |
ESCC, |
TE1 |
|
|
|
- |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
- |
vitro+vivo, |
SCC, |
KYSE150 |
|
|
|
TumCP↓, TumCMig↓, MMP2↓, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, BAX↑, Bcl-2↓, p‑p38↓, TumCG↓,
| - |
in-vitro, |
ESCC, |
KYSE-30 |
|
|
|
Pyro↑, TumCP↓, TumCMig↓, TumCI↓, ASC↑, cl‑Casp1↑, NLRP3↑, GSDMD↑, ROS↑, NRF2↓, TXNIP↑,
TumCP↓, TumCMig↓, PKA↓, GlucoseCon↓, lactateProd↓, PKM2↓, STAT3↓, cMyc↓,
tumCV↓, TumCMig↓, TumCI↓, TumAuto↑, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑PARP↑, AMPK↑, mTOR↑, TumVol↓, OS↑, LC3I↑,
Showing Research Papers: 1 to 14 of 14
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 14
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
HK1↓, 1, NRF2↓, 1, ROS↑, 3,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, Raf↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALDOA↓, 1, AMPK↑, 1, p‑AMPK↑, 1, cMyc↓, 2, ECAR↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, PKM2↓, 2, SIRT1↑, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, p‑Akt↓, 4, Apoptosis↓, 2, Apoptosis↑, 8, BAX↑, 5, Bax:Bcl2↑, 1, Bcl-2↓, 4, cl‑Casp1↑, 1, Casp3↑, 3, cl‑Casp3↑, 3, cl‑Casp8↑, 1, Casp9↑, 2, cl‑Casp9↑, 2, GSDMD↑, 1, MAPK↓, 1, p‑p38↓, 1, Pyro↑, 1, survivin↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 2,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3I↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 2, P53↑, 1, cl‑PARP↑, 2, cl‑PARP1↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 3, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ALDH↓, 1, EMT↓, 3, p‑ERK↓, 2, mTOR↑, 1, p‑mTOR↓, 1, PI3K↓, 3, PTEN↑, 1, RAS↓, 1, STAT3↓, 1, p‑STAT3↓, 1, p‑STAT3↑, 1, TumCG↓, 5,
Migration(tgid=13) ⓘ
MMP2↓, 3, MMP9↓, 3, MMPs↓, 1, PAK1↓, 1, PKA↓, 1, TumCI↓, 11, TumCMig↓, 14, TumCP↓, 10, TumMeta↓, 2, TXNIP↑, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ASC↑, 1, p‑IκB↑, 1, NF-kB↓, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 3, eff↑, 1, RadioS↑, 1,
Functional Outcomes(tgid=23) ⓘ
OS↑, 1, toxicity↓, 1, TumVol↓, 1,
Total Targets: 83
Pathway results for Effect on Normal Cells:
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: TumCMig, Tumor cell migration
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:41 Cells:% prod#:% Target#:326 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page